Medical Care

Global Cancer Biotherapy Market Research Report 2025

This report aims to provide a comprehensive presentation of the global market for Cancer Biotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Biotherapy.
The Cancer Biotherapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancer Biotherapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Biotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Bristol-Myers Squibb
Celgene
GlaxoSmithKline
Eli Lilly
Segment by Type
Monoclonal Antibodies
Vaccines
Erythropoietin
Colony Stimulating Factors
Interleukins and Interferons
Segment by Application
Hospitals
Diagnostic Laboratories
Research and Academic Laboratories
Pharmaceutical and Biotechnology Companies
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Biotherapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Biotherapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal Antibodies
1.2.3 Vaccines
1.2.4 Erythropoietin
1.2.5 Colony Stimulating Factors
1.2.6 Interleukins and Interferons
1.3 Market by Application
1.3.1 Global Cancer Biotherapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Research and Academic Laboratories
1.3.5 Pharmaceutical and Biotechnology Companies
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Biotherapy Market Perspective (2020-2031)
2.2 Global Cancer Biotherapy Growth Trends by Region
2.2.1 Global Cancer Biotherapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cancer Biotherapy Historic Market Size by Region (2020-2025)
2.2.3 Cancer Biotherapy Forecasted Market Size by Region (2026-2031)
2.3 Cancer Biotherapy Market Dynamics
2.3.1 Cancer Biotherapy Industry Trends
2.3.2 Cancer Biotherapy Market Drivers
2.3.3 Cancer Biotherapy Market Challenges
2.3.4 Cancer Biotherapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Biotherapy Players by Revenue
3.1.1 Global Top Cancer Biotherapy Players by Revenue (2020-2025)
3.1.2 Global Cancer Biotherapy Revenue Market Share by Players (2020-2025)
3.2 Global Cancer Biotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cancer Biotherapy Revenue
3.4 Global Cancer Biotherapy Market Concentration Ratio
3.4.1 Global Cancer Biotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Biotherapy Revenue in 2024
3.5 Global Key Players of Cancer Biotherapy Head office and Area Served
3.6 Global Key Players of Cancer Biotherapy, Product and Application
3.7 Global Key Players of Cancer Biotherapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Biotherapy Breakdown Data by Type
4.1 Global Cancer Biotherapy Historic Market Size by Type (2020-2025)
4.2 Global Cancer Biotherapy Forecasted Market Size by Type (2026-2031)
5 Cancer Biotherapy Breakdown Data by Application
5.1 Global Cancer Biotherapy Historic Market Size by Application (2020-2025)
5.2 Global Cancer Biotherapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cancer Biotherapy Market Size (2020-2031)
6.2 North America Cancer Biotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cancer Biotherapy Market Size by Country (2020-2025)
6.4 North America Cancer Biotherapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Biotherapy Market Size (2020-2031)
7.2 Europe Cancer Biotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cancer Biotherapy Market Size by Country (2020-2025)
7.4 Europe Cancer Biotherapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Biotherapy Market Size (2020-2031)
8.2 Asia-Pacific Cancer Biotherapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cancer Biotherapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Cancer Biotherapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Biotherapy Market Size (2020-2031)
9.2 Latin America Cancer Biotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cancer Biotherapy Market Size by Country (2020-2025)
9.4 Latin America Cancer Biotherapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Biotherapy Market Size (2020-2031)
10.2 Middle East & Africa Cancer Biotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cancer Biotherapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Cancer Biotherapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Cancer Biotherapy Introduction
11.1.4 Amgen Revenue in Cancer Biotherapy Business (2020-2025)
11.1.5 Amgen Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Cancer Biotherapy Introduction
11.2.4 Bristol-Myers Squibb Revenue in Cancer Biotherapy Business (2020-2025)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Celgene
11.3.1 Celgene Company Details
11.3.2 Celgene Business Overview
11.3.3 Celgene Cancer Biotherapy Introduction
11.3.4 Celgene Revenue in Cancer Biotherapy Business (2020-2025)
11.3.5 Celgene Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Cancer Biotherapy Introduction
11.4.4 GlaxoSmithKline Revenue in Cancer Biotherapy Business (2020-2025)
11.4.5 GlaxoSmithKline Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Details
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Cancer Biotherapy Introduction
11.5.4 Eli Lilly Revenue in Cancer Biotherapy Business (2020-2025)
11.5.5 Eli Lilly Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Cancer Biotherapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Vaccines
Table 4. Key Players of Erythropoietin
Table 5. Key Players of Colony Stimulating Factors
Table 6. Key Players of Interleukins and Interferons
Table 7. Global Cancer Biotherapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Cancer Biotherapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Cancer Biotherapy Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Cancer Biotherapy Market Share by Region (2020-2025)
Table 11. Global Cancer Biotherapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Cancer Biotherapy Market Share by Region (2026-2031)
Table 13. Cancer Biotherapy Market Trends
Table 14. Cancer Biotherapy Market Drivers
Table 15. Cancer Biotherapy Market Challenges
Table 16. Cancer Biotherapy Market Restraints
Table 17. Global Cancer Biotherapy Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Cancer Biotherapy Market Share by Players (2020-2025)
Table 19. Global Top Cancer Biotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biotherapy as of 2024)
Table 20. Ranking of Global Top Cancer Biotherapy Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Cancer Biotherapy Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Cancer Biotherapy, Headquarters and Area Served
Table 23. Global Key Players of Cancer Biotherapy, Product and Application
Table 24. Global Key Players of Cancer Biotherapy, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cancer Biotherapy Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Cancer Biotherapy Revenue Market Share by Type (2020-2025)
Table 28. Global Cancer Biotherapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Cancer Biotherapy Revenue Market Share by Type (2026-2031)
Table 30. Global Cancer Biotherapy Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Cancer Biotherapy Revenue Market Share by Application (2020-2025)
Table 32. Global Cancer Biotherapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Cancer Biotherapy Revenue Market Share by Application (2026-2031)
Table 34. North America Cancer Biotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Cancer Biotherapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Cancer Biotherapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Cancer Biotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Cancer Biotherapy Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Cancer Biotherapy Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Cancer Biotherapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Cancer Biotherapy Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Cancer Biotherapy Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Cancer Biotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Cancer Biotherapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Cancer Biotherapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Cancer Biotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Cancer Biotherapy Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Cancer Biotherapy Market Size by Country (2026-2031) & (US$ Million)
Table 49. Amgen Company Details
Table 50. Amgen Business Overview
Table 51. Amgen Cancer Biotherapy Product
Table 52. Amgen Revenue in Cancer Biotherapy Business (2020-2025) & (US$ Million)
Table 53. Amgen Recent Development
Table 54. Bristol-Myers Squibb Company Details
Table 55. Bristol-Myers Squibb Business Overview
Table 56. Bristol-Myers Squibb Cancer Biotherapy Product
Table 57. Bristol-Myers Squibb Revenue in Cancer Biotherapy Business (2020-2025) & (US$ Million)
Table 58. Bristol-Myers Squibb Recent Development
Table 59. Celgene Company Details
Table 60. Celgene Business Overview
Table 61. Celgene Cancer Biotherapy Product
Table 62. Celgene Revenue in Cancer Biotherapy Business (2020-2025) & (US$ Million)
Table 63. Celgene Recent Development
Table 64. GlaxoSmithKline Company Details
Table 65. GlaxoSmithKline Business Overview
Table 66. GlaxoSmithKline Cancer Biotherapy Product
Table 67. GlaxoSmithKline Revenue in Cancer Biotherapy Business (2020-2025) & (US$ Million)
Table 68. GlaxoSmithKline Recent Development
Table 69. Eli Lilly Company Details
Table 70. Eli Lilly Business Overview
Table 71. Eli Lilly Cancer Biotherapy Product
Table 72. Eli Lilly Revenue in Cancer Biotherapy Business (2020-2025) & (US$ Million)
Table 73. Eli Lilly Recent Development
Table 74. Research Programs/Design for This Report
Table 75. Key Data Information from Secondary Sources
Table 76. Key Data Information from Primary Sources
Table 77. Authors List of This Report


List of Figures
Figure 1. Cancer Biotherapy Picture
Figure 2. Global Cancer Biotherapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cancer Biotherapy Market Share by Type: 2024 VS 2031
Figure 4. Monoclonal Antibodies Features
Figure 5. Vaccines Features
Figure 6. Erythropoietin Features
Figure 7. Colony Stimulating Factors Features
Figure 8. Interleukins and Interferons Features
Figure 9. Global Cancer Biotherapy Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Cancer Biotherapy Market Share by Application: 2024 VS 2031
Figure 11. Hospitals Case Studies
Figure 12. Diagnostic Laboratories Case Studies
Figure 13. Research and Academic Laboratories Case Studies
Figure 14. Pharmaceutical and Biotechnology Companies Case Studies
Figure 15. Others Case Studies
Figure 16. Cancer Biotherapy Report Years Considered
Figure 17. Global Cancer Biotherapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 18. Global Cancer Biotherapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global Cancer Biotherapy Market Share by Region: 2024 VS 2031
Figure 20. Global Cancer Biotherapy Market Share by Players in 2024
Figure 21. Global Top Cancer Biotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biotherapy as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Cancer Biotherapy Revenue in 2024
Figure 23. North America Cancer Biotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. North America Cancer Biotherapy Market Share by Country (2020-2031)
Figure 25. United States Cancer Biotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Canada Cancer Biotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Cancer Biotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Cancer Biotherapy Market Share by Country (2020-2031)
Figure 29. Germany Cancer Biotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. France Cancer Biotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. U.K. Cancer Biotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Italy Cancer Biotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Russia Cancer Biotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Nordic Countries Cancer Biotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Cancer Biotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Cancer Biotherapy Market Share by Region (2020-2031)
Figure 37. China Cancer Biotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Japan Cancer Biotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. South Korea Cancer Biotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Cancer Biotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. India Cancer Biotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Australia Cancer Biotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Cancer Biotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Cancer Biotherapy Market Share by Country (2020-2031)
Figure 45. Mexico Cancer Biotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Brazil Cancer Biotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Cancer Biotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Cancer Biotherapy Market Share by Country (2020-2031)
Figure 49. Turkey Cancer Biotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Cancer Biotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. UAE Cancer Biotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Amgen Revenue Growth Rate in Cancer Biotherapy Business (2020-2025)
Figure 53. Bristol-Myers Squibb Revenue Growth Rate in Cancer Biotherapy Business (2020-2025)
Figure 54. Celgene Revenue Growth Rate in Cancer Biotherapy Business (2020-2025)
Figure 55. GlaxoSmithKline Revenue Growth Rate in Cancer Biotherapy Business (2020-2025)
Figure 56. Eli Lilly Revenue Growth Rate in Cancer Biotherapy Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies